FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC)

CUSIP: 31447P100

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Shares, no par value
Shares outstanding
34,763,175
Total 13F shares
15,538,482
Share change
+1,579,597
Total reported value
$119,646,345
Price per share
$7.70
Number of holders
95
Value change
+$11,219,093
Number of buys
44
Number of sells
32

Quarterly Holders Quick Answers

What is CUSIP 31447P100?
CUSIP 31447P100 identifies FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Southpoint Capital Advisors LP
13F 13D/G 3/4/5
Company · Southpoint Master Fund, LP · 10%+ Owner
8%
from 13D/G
4,077,214
$38,162,723 30 Sep 2025
Sonic Fund II, L.P.
13D/G
Kam Lawrence
8.2%
2,799,959
$21,503,685 $0 31 Dec 2025
Rosalind Advisors, Inc.
13D/G 13F
Company
9.8%
2,746,840
$21,095,731 +$5,145,600 31 Dec 2025
Solas Capital Management, LLC
13F 13D/G
Company
8.2%
from 13D/G
2,187,902
$20,478,763 30 Sep 2025
BlackRock, Inc.
13F
Company
3.5%
1,211,806
$11,342,505 30 Sep 2025
13F
VANGUARD GROUP INC
13F
Company
2.7%
955,764
$8,945,951 30 Sep 2025
13F
AIGH Capital Management LLC
13F
Company
2%
681,501
$6,378,850 30 Sep 2025
13F
DG Capital Management, LLC
13D/G
4.1%
1,114,692
$6,342,597 $0 31 Dec 2024
STATE STREET CORP
13F
Company
0.98%
341,201
$3,193,641 30 Sep 2025
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
0.96%
334,593
$3,131,790 30 Sep 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.87%
300,772
$2,815,225 30 Sep 2025
13F
MORGAN STANLEY
13F
Company
0.67%
232,402
$2,175,283 30 Sep 2025
13F
Chris A. Rallis
3/4/5
Director
mixed-class rows
257,612
mixed-class rows
$2,107,609 -$26,147 10 Oct 2025
Khalid Islam
3/4/5
Director
class O/S missing
225,000
$1,773,000 03 Jun 2025
Marco Maria Brughera
3/4/5
Director
class O/S missing
215,545
$1,698,494 03 Jun 2025
HARBERT FUND ADVISORS, INC.
13F
Company
0.51%
177,815
$1,664,348 30 Sep 2025
13F
Jeffrey L. Gendell
13F
Individual
0.4%
139,559
$1,306,272 30 Sep 2025
13F
NORTHERN TRUST CORP
13F
Company
0.38%
130,553
$1,221,976 30 Sep 2025
13F
Lion Point Capital, LP
13F
Company
0.35%
123,000
$1,151,280 30 Sep 2025
13F
Jodi A. Cook
3/4/5
Director
class O/S missing
140,000
$1,103,200 03 Jun 2025
CITADEL ADVISORS LLC
13F
Company
0.31%
107,496
$1,006,163 30 Sep 2025
13F
Adrian Haigh
3/4/5
CHIEF OPERATING OFFICER
mixed-class rows
1,205,738
mixed-class rows
$832,168 16 May 2024
JANE STREET GROUP, LLC
13F
Company
0.21%
72,631
$679,826 30 Sep 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.16%
57,249
$535,851 30 Sep 2025
13F
Bank of New York Mellon Corp
13F
Company
0.15%
52,278
$489,325 30 Sep 2025
13F
Hartford Financial Management Inc.
13F
Company
0.15%
50,646
$474,047 30 Sep 2025
13F
RHUMBLINE ADVISERS
13F
Company
0.1%
33,522
$313,757 30 Sep 2025
13F
BARCLAYS PLC
13F
Company
0.1%
33,038
$309,236 30 Sep 2025
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.09%
32,100
$300,456 30 Sep 2025
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.09%
30,700
$287,352 30 Sep 2025
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.08%
27,055
$253,235 30 Sep 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.08%
26,490
$247,946 30 Sep 2025
13F
Nuveen, LLC
13F
Company
0.07%
26,006
$243,416 30 Sep 2025
13F
SIMPLEX TRADING, LLC
13F
Company
0.06%
21,270
$199,000 30 Sep 2025
13F
XTX Topco Ltd
13F
Company
0.06%
21,247
$198,872 30 Sep 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.05%
17,023
$159,335 30 Sep 2025
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.05%
17,015
$159,260 30 Sep 2025
13F
FRANKLIN RESOURCES INC
13F
Company
0.05%
16,978
$158,914 30 Sep 2025
13F
Quadrature Capital Ltd
13F
Company
0.04%
15,321
$143,558 30 Sep 2025
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.04%
15,012
$140,512 30 Sep 2025
13F
HighTower Advisors, LLC
13F
Company
0.04%
15,000
$140,400 30 Sep 2025
13F
UBS Group AG
13F
Company
0.04%
13,710
$128,326 30 Sep 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.04%
13,443
$125,826 30 Sep 2025
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.04%
12,504
$118,000 30 Sep 2025
13F
Invesco Ltd.
13F
Company
0.03%
12,127
$113,509 30 Sep 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.03%
12,077
$113,041 30 Sep 2025
13F
INTECH INVESTMENT MANAGEMENT LLC
13F
Company
0.03%
11,384
$106,554 30 Sep 2025
13F
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
13F
Company
0.03%
10,893
$101,958 30 Sep 2025
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.03%
10,708
$100,000 30 Sep 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.03%
10,600
$99,216 30 Sep 2025
13F

Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) as of Q4 2025

As of 31 Dec 2025, FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) was held by 95 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,538,482 shares. The largest 10 holders included Southpoint Capital Advisors LP, Rosalind Advisors, Inc., Solas Capital Management, LLC, AIGH Capital Management LLC, BlackRock, Inc., VANGUARD GROUP INC, AWM Investment Company, Inc., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and MORGAN STANLEY. This page lists 95 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
83
Q4 2025 holders
95
Holder diff
12
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .